Divi's Laboratories Ltd

Common Name
Divi's Laboratories
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
10,542
Ticker
DIVISLAB
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Divi's Laboratories Ltd. is a prominent pharmaceutical company based in India, renowned for its research-driven approach in the development and manufacturing of active pharmaceutical ingredients (APIs...

Divi's Laboratories's GHG Emissions Data Preview

In 2025, Divi's Laboratories completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, Divi's Laboratories has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2025202420232022 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Download Data

Verified Sources Behind Divi's Laboratories’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Divi's Laboratories’s data sources below and access millions more through our Disclosure Search.

a. Divi's Laboratories's Sustainability Report 2025
a. Divi's Laboratories's Sustainability Report 2025
b. Divi's Laboratories's Annual Report 2023
b. Divi's Laboratories's Annual Report 2023
c. Divi's Laboratories's Sustainability Report 2022
c. Divi's Laboratories's Sustainability Report 2022

Insights into Divi's Laboratories's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Divi's Laboratories amounted to 697,751 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Divi's Laboratories increased by 1.24%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Divi's Laboratories's Scope 1 Emissions Over Time

201820192020202120222023202420250150 k300 k450 k600 ktCO2e+16%-5%+25%-13%-1%-5%-6%
  • Total Scope 1
  • Year-over-Year Change

What are Divi's Laboratories's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Divi's Laboratories were 339,941 metric tons of CO₂ equivalent (tCO₂e). a

Has Divi's Laboratories reduced its Scope 1 emissions over time?

Since 2018, Divi's Laboratories's Scope 1 emissions have increased by 6.15%, reflecting a rising long-term trend in Scope 1 emissions over time. a c

Compared to the previous year (2024), Divi's Laboratories's Scope 1 emissions decreased by 6.42%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Divi's Laboratories's Scope 2 emissions?

In 2025, Divi's Laboratories reported Scope 2 greenhouse gas (GHG) emissions of 357,810 tCO₂e without specifying the calculation method. a

Has Divi's Laboratories reduced its Scope 2 emissions over time?

Since 2018, Divi's Laboratories's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 41.35%, reflecting a rising long-term trend in Scope 2 emissions over time. a c

Compared to the previous year (2024), Divi's Laboratories's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Divi's Laboratories 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Divi's Laboratories use for Scope 2 reporting?

In 2025, Divi's Laboratories reported its Scope 2 emissions using an unspecified methodology. a

Divi's Laboratories's Scope 2 Emissions Over Time

20182019202020212022202320242025095 k190 k285 k380 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Divi's Laboratories's Value Chain Emissions

In 2025, Divi's Laboratories reported 896,952 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2025 disclosure of Divi's Laboratories includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

Divi's Laboratories's Scope 3 Emissions Over Time

2022202420250250 k500 k750 k1 MtCO2e+1804%+8%
  • Total Scope 3
  • Year-over-Year Change

What are Divi's Laboratories's Scope 3 emissions?

In 2025, Divi's Laboratories reported total Scope 3 emissions of 896,952 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2024), Divi's Laboratories's Scope 3 emissions remained relatively stable, indicating that Divi's Laboratories 's emissions have plateaued with no significant change in its value chain footprint. a

Insights into Divi's Laboratories’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Divi's Laboratories reported Scope 1 greenhouse gas (GHG) emissions of 339,941 tCO₂e and total revenues of USD 1,091 millions. This translates into an emissions intensity of 311.47 tCO₂e per millions USD. a

Divi's Laboratories's Scope 1 Emissions Intensity Compared to Peers

1001,00020,000200,0002,000,000Scope 1 Emissions (tCO2e)502001,0002,00010,000Revenues (Millions of USD)OJAurobindo PharmaYear: 2025Scope 1: 750,616 tCO2eRevenue: $M 3,672Scope 1 Intensity: 204.39 tCO2e/$MMankind PharmaYear: 2025Scope 1: 6,538 tCO2eRevenue: $M 1,429Scope 1 Intensity: 4.58 tCO2e/$MZydus LifesciencesYear: 2023Scope 1: 44,792 tCO2eRevenue: $M 2,056Scope 1 Intensity: 21.79 tCO2e/$MAarti PharmalabsYear: 2024Scope 1: 88,101 tCO2eRevenue: $M 218Scope 1 Intensity: 404.68 tCO2e/$MAlembic PharmaceuticalsYear: 2025Scope 1: 80,278 tCO2eRevenue: $M 765Scope 1 Intensity: 104.88 tCO2e/$MAjanta PharmaYear: 2025Scope 1: 6,392 tCO2eRevenue: $M 537Scope 1 Intensity: 11.90 tCO2e/$MAbbott IndiaYear: 2025Scope 1: 232 tCO2eRevenue: $M 750Scope 1 Intensity: 0.31 tCO2e/$MCiplaYear: 2025Scope 1: 38,283 tCO2eRevenue: $M 3,177Scope 1 Intensity: 12.05 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MTorrent PharmaceuticalsYear: 2025Scope 1: 8,937 tCO2eRevenue: $M 1,325Scope 1 Intensity: 6.75 tCO2e/$MStrides Pharma ScienceYear: 2023Scope 1: 6,168 tCO2eRevenue: $M 439Scope 1 Intensity: 14.04 tCO2e/$MCohance LifesciencesYear: 2025Scope 1: 31,818 tCO2eRevenue: $M 140Scope 1 Intensity: 227.00 tCO2e/$MOOOrchid PharmaYear: 2025Scope 1: 74,800 tCO2eRevenue: $M 108Scope 1 Intensity: 693.22 tCO2e/$MAlkem LaboratoriesYear: 2025Scope 1: 33,018 tCO2eRevenue: $M 1,499Scope 1 Intensity: 22.03 tCO2e/$MGland PharmaYear: 2025Scope 1: 13,920 tCO2eRevenue: $M 654Scope 1 Intensity: 21.30 tCO2e/$MLupinYear: 2025Scope 1: 82,174 tCO2eRevenue: $M 2,597Scope 1 Intensity: 31.64 tCO2e/$MSun Pharmaceutical IndustriesYear: 2025Scope 1: 156,242 tCO2eRevenue: $M 6,091Scope 1 Intensity: 25.65 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$MDr Reddy's LaboratoriesYear: 2025Scope 1: 142,772 tCO2eRevenue: $M 3,810Scope 1 Intensity: 37.47 tCO2e/$MGranules IndiaYear: 2024Scope 1: 58,254 tCO2eRevenue: $M 538Scope 1 Intensity: 108.19 tCO2e/$MDivi's LaboratoriesYear: 2025Scope 1: 339,941 tCO2eRevenue: $M 1,091Scope 1 Intensity: 311.47 tCO2e/$M

How does Divi's Laboratories's GHG emissions intensity compare to its peers?

In 2025, Divi's Laboratories reported a Scope 1 emissions intensity of 311.47 tCO₂e per millions USD. Compared to the peer group median of 24.05 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does Divi's Laboratories rank on GHG emissions intensity within its industry?

In 2025, Divi's Laboratories ranked 23 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Divi's Laboratories among the least efficient performers, with one of the highest emissions intensities in its sector. a

Insights into Divi's Laboratories's Total Carbon Footprint

In 2025, Divi's Laboratories reported a total carbon footprint of 1,594,703 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 4.82% increase compared to 2024, suggesting a rise in emissions across its operations or value chain. a

The largest contributor to Divi's Laboratories's total carbon footprint was Scope 3 emissions, accounting for 56.25% of the company's total carbon footprint, followed by Scope 2 emissions at 22.44%. a

Want Full Access to Divi's Laboratories's GHG Emissions Dataset?
Sign Up